Exam 2 - Vancomycin & GP agents Flashcards

1
Q

what are the two main groups Vanc has coverage for

A

GP aerobic and anaerobic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what target organisms does vanc cover

A

PSSP
PRSP
Enterococcus
MSSA
MRSA
C. diff (PO dose only)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

GN coverage of Vanc

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is vanc THE drug of choice for

A

MRSA
C. diff (po dose only)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

clinical uses of vanc

A

MRSA infections (even in the CNS)
Serious GP infections for pts allergic to penicillins
PRSP infections/resistant GP organisms
prophylaxis of high risk surgeries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

GP coverage for synercid

A

PSSP
PRSP
Enterococcus Faecium ONLY (including VRE)
MSSA
MRSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

GN and atypical coverage for vanc

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

when to use synercid

A

only when vanc, linezolid, and daptomycin cannot be used
Enterococcus faecium (VRE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

GP coverage for linezolid

A

PSSP, PRSP
Enterococcus faecium AND faecalis (including VRE)
MSSA, MRSA, VISA, VRSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GN and atypical coverage for linezolide

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

when to use linezolid

A

when vanc or b-lactams cannot be used
-VRE infections
-Nosocomial pneumonia from MRSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is linezolid the drug of choice for

A

VRE infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

GP coverage of daptomycin

A

PSSP, PRSP
Enterococcus Faecium AND Faecalis (including VRE)
MSSA, MRSA, VISA, VRSA, LRSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

GN coverage of daptomycin

A

NONE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

when to use daptomycin

A

when vanc and linezolid cant be used
-staph aureus bacteremia and endocarditis
-MRSA or VRE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what infection should daptomycin NOT be used in

A

treatment of pneumonia
due to inactivation by pulmonary surfactant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are the lipoglycopeptides

A

telavancin, dalbavancin, oritavancin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

GP coverage for lipoglycopeptides

A

PSSP, PRSP
Enterococcus Faecium and Faecalis
Staph A infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what place in therapy are lipoglycopeptides for GP bugs

A

last line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

vanc moa

A

-inhibits synthesis of cell wall at different site than B-lactams
-inhibits synthesis and assembly during second stage (D-ala-D-ala)
-prevents cross linking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what kind of killers are vanc

A

bactericidal slooooooow killers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is the resistance against vanc

A

Showed in Enterococcus (VRE) and Staph A (VRSA) due to modification of the D-ala to d-lactate
also in VISA due to thickening of cell wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what do you target for clinical efficacy of vanc

A

AUC/MIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what is the route of admin for vanc

A

IM and IV (preferred)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

where does vanc distribute

A

widely distributed (adipose) AND the CNS even w/ inflamed meninges

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

how long does vanc take to distribute

A

one hour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what weight do you use to dose vanc

A

TBW

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

how is vanc eliminated

A

unchanged by the kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what is the half life of vanc and how can it be affected

A

6-8 hours and increases as renal function decreases (7-14 days)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

is vanc removed during dialysis

A

somewhat 30-40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

why should serum conc. be monitored with vanc

A

high concentrations can lead to nephrotoxicity

32
Q

when to draw concentrations for vanc

A

Peak: one hour after end of infusion
Trough: just prior to dose

33
Q

what should doses not exceed for vanc

A

2000-3000mg

34
Q

what are the adverse effects of vanc

A

Red-Man Syndrome
Nephrotoxicity
Ototoxicity
Dermatologic
Hematologic

35
Q

what can cause red-man syndrome

A

rate of the vanc infusion

36
Q

how to mitigate red-man syndrome

A

vanc doses of 1g should be infused over at least 1 hour and larger doses over 90-120 minutes

37
Q

what are risk factors for nephro and ototoxicity for vanc

A

underlying renal insufficiency

38
Q

synercid moa

A

on the 50S subunit

39
Q

what kind of killer is synercid

A

time dependent
bacteriostatic alone and bactericidal together

40
Q

what is the resistance against synercid

A

alteration of ribosomal binding site by the erm gene

41
Q

does synercid have a PAE

A

yes and allows for extended dosing

42
Q

does synercid need to be adjusted for anything?

A

no adjustment for renal insufficiency
should adjust in hepatic insufficiency

43
Q

DDIs of synercid

A

statins
immunosuppressors (cyclosporine and tacrolimus)
Carbamazepine

44
Q

what are the AEs for synercid

A

vein irritation
GI
myalgias/arthralgias
rash

45
Q

linezolid moa

A

binds to 50s subunit near the 30s to prevent 70s complex
inhibits protein synthesis

46
Q

what kind of killers are linezolid

A

bacteriostatic

47
Q

what is the resistance against linezolid

A

alteration of subunit target
(not erm though)

48
Q

does linezolid have PAE

49
Q

what is the absorption for linezolid

A

100% oral bioavailability

50
Q

what is the distribution of linezolid

A

readily distributes into well-perfused tissues
limited CSF access

51
Q

how is linezolid eliminated

A

renal and hepatic

52
Q

dose adjustments for linezolid

A

none for renal insufficiency

53
Q

DDIs of linezolid

A

weak inhibitors of Monoamine oxidase
serotonin syndrome

54
Q

can linezolid be used with SSRIs

A

yes, but you have to counsel patient on how to monitor for serotonin syndrome

55
Q

what are the adverse effects of linezolid

A

GI
peripheral and optic neuropathy
thrombocytopenia and anemia

56
Q

what should ALWAYS be checked before starting linezolid

A

SSRI use and platelets < 50,000

57
Q

daptomycin moa

A

binds to membrane and inserts tail into cell wall

58
Q

what kind of killer is daptomycin

A

rapid concentration dependent bactericidal activity

59
Q

what is the resistance against daptomycin

A

altered cell-membrane (rare)

60
Q

route of admin for dapto

61
Q

distribution of daptomycin

A

fairly well into tissue
NO CNS

62
Q

elimination of daptomycin

A

via the kidneys

63
Q

dosage adjustment of daptomycin

A

required for renal insufficiency

64
Q

DDI of daptomycin

65
Q

adverse effects of daptomycin

A

GI
Headache
Injection site reactions
Rash
Myopathy and CPK elevation
Acute eosinophilic penumonia

66
Q

moa of lipoglycopeptides

A

interfere with d-ala-d-ala
only oritavancin and telavancin will insert the tail)

67
Q

resistance against lipoglycopeptides

A

alteration in the D-ala to D-lactate

68
Q

what kind of killers are lipoglycopeptides

A

concentration-dependent bactericidal activity

69
Q

distribution of lipoglycopeptides

A

well into tissues
NO CNS

70
Q

what lipoglycopeptides are removed by HD

71
Q

what lipoglycopeptides need adjusted for renal insufficiency

A

telavancin and dalbavancin

72
Q

what lipoglycopeptide does NOT need adjusted for renal

A

oritavancin

73
Q

adverse effects of lipoglycopeptides

A

red man syndrome
nephrotoxicity
QTc - prolongation
taste disturbances

74
Q

what is the risk you run with lipoglycopeptides?

A

if a patient experiences a bad reaction, the half-life is so long they will take a while to go away

75
Q

lipoglycopeptides in pregnancy

A

telavancin has a black box warning for pregnancy
dalba and orita are also due to lack of studies